Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

August 23, 2019 | Daily News

Senate Homeland Security & Government Affairs Committee ranking Democrat Gary Peters (MI) is concerned FDA doesn’t have the data it needs to mitigate drug shortages, which he says can drive up prices and hurt patients and hospitals.

August 22, 2019 | Daily News

Democratic staff of the House Energy & Commerce Committee are not negotiating on drug pricing with staff of the Senate Finance Committee, sources say, even though Finance Chair Chuck Grassley (R-IA) said bicameral drug-pricing talks would occur in August.

August 21, 2019 | Daily News

The pharmaceutical industry, including GW Pharmaceuticals, the producer of cannabidiol-containing drug Epidiolex, warns FDA that allowing CBD in consumer products could freeze research and development on use of CBD in prescription drugs.

August 21, 2019 | Daily News

HHS will appeal a court decision that struck down a Trump administration rule requiring drug makers to disclose list prices in television advertisements, the department said in a court filing on Wednesday (Aug. 21).

August 21, 2019 | Daily News

Women’s health experts, including former FDA chief Jane Henney and Planned Parenthood, argue FDA should drop its dispensing restrictions on “abortion pill” mifepristone as those restrictions continue to severely limit patient access to medication that health care provider groups already agree is safe.

August 20, 2019 | Daily News

FDA’s pediatric advisory committee will meet late next month to discuss the safety of opioids to manage pain in children, and to share the results of a study on the neuropsychiatric effects of an asthma drug called montelukast, more commonly known as Singulair.

August 20, 2019 | Daily News

FDA on Monday (Aug. 19) announced the approval of a first-in-class antibiotic to treat adults with community-acquired bacterial pneumonia, which means the pneumonia was acquired outside of a hospital.

August 17, 2019 | Daily News

Senate Finance Chair Chuck Grassley said Friday (Aug. 16) that Senate staff are pre-negotiating with House Democrats on drug-pricing legislation that could pass the lower chamber in a bid to pressure Senate Majority Leader Mitch McConnell (R-KY) to hold a Senate vote.

August 16, 2019 | Daily News

White House budget officials and the Pharmaceutical Research and Manufacturers of America are scheduled to meet Aug. 26 to discuss the Trump administration’s plan to tie U.S. drug prices to those in foreign countries, according to the Office of Management and Budget website.

August 16, 2019 | Daily News

CMS Administrator Seema Verma declined to say whether the Medicare International Pricing Index is a separate initiative from the so-called favored-nations executive order the president is writing to ensure the United States pays no more for drugs than other countries.

August 16, 2019 | Daily News

FDA on Thursday (Aug. 16) approved a third tissue-agnostic cancer treatment that targets biomarkers found in a multiple different tumor types rather than one specific location in the body.

August 15, 2019 | Daily News

Experts say that a cultural change in industry is needed to get drug makers to focus more on precision dosing for drugs, and that both FDA and payers could help push industry in that direction.

August 15, 2019 | Daily News

FDA’s approval Wednesday (Aug. 14) of a new drug for treatment-resistant forms of tuberculosis developed by the nonprofit TB Alliance refueled debate on the role the government and nonprofits could play in spurring the development of new antibiotics.

August 15, 2019 | Daily News

Track-and-trace requirements pose an obstacle for states that plan to import prescription drugs from Canada, supply chain experts say. However, FDA could issue guidance to help states get around the track-and-trace requirements.

August 14, 2019 | Daily News

Generic drug makers in the United States could experience an uptick in competition from China in the next 10 years, according to a non-profit think tank that focuses on public policy and innovation.

August 14, 2019 | Daily News

Seniors’ out-of-pocket maximum in Medicare Part D is set to increase 25% in 2020, and lawmakers have shown no indication that they will address the problem before the end of 2019.

August 14, 2019 | Daily News

The Government Accountability Office verified both drug makers’ assertions that the amount of rebates they pay is rising much faster than drug net prices and pharmacy benefit managers’ assertion that they pass nearly all rebates to their insurer clients.

August 13, 2019 | Daily News

FDA warned domestic and foreign drug makers that beginning Sept. 12 it will inactivate drug listings in the National Drug Code (NDC) directory that haven’t been recently updated or certified or that include an establishment with an expired registration.

August 12, 2019 | Daily News

John O’Brien, HHS’ top drug-pricing official, is stepping down after nine months and will be replaced by John Brooks, the principal deputy director of the Center for Medicare and formerly a White House Domestic Policy Council official, HHS announced Monday (Aug. 12). The departure comes after several of President Donald Trump’s marquee drug-pricing policies were blocked or pulled in recent months.

August 12, 2019 | Daily News

FDA will hold a public meeting on Nov. 7 to solicit ideas on ways to improve the drug development process, including through new trial designs such as master protocols that could cross multiple therapeutic areas and be implemented in the near term, the agency announced Friday (Aug. 9).

Pages